CY1107410T1 - USE A SIGNIFICANT TEMPLATE SPECIFIED FOR THE HUMAN MOTION CD4 - Google Patents

USE A SIGNIFICANT TEMPLATE SPECIFIED FOR THE HUMAN MOTION CD4

Info

Publication number
CY1107410T1
CY1107410T1 CY20081100415T CY081100415T CY1107410T1 CY 1107410 T1 CY1107410 T1 CY 1107410T1 CY 20081100415 T CY20081100415 T CY 20081100415T CY 081100415 T CY081100415 T CY 081100415T CY 1107410 T1 CY1107410 T1 CY 1107410T1
Authority
CY
Cyprus
Prior art keywords
human motion
human
template specified
molecule
significant
Prior art date
Application number
CY20081100415T
Other languages
Greek (el)
Inventor
Frank Emmrich
Raimund W Kinne
Rüdiger LAUB
Ullrich Pigla
Original Assignee
Biotectid Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02804582A external-priority patent/EP1454137B1/en
Application filed by Biotectid Gmbh filed Critical Biotectid Gmbh
Publication of CY1107410T1 publication Critical patent/CY1107410T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/13—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultrasonic waves
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η εφεύρεση αφορά τη χρησιμοποίηση ενός σημασμένου προσδέματος με εξειδίκευση για το ανθρώπινο μόριο CD4 για την παρασκευή ενός διαγνωστικού μέσου για την ανάλυση προτύπων μετανάστευσης και/ή κατανομής ορισμένων πληθυσμών κυττάρων, οι οποίοι περιλαμβάνουν κύτταρα που φέρουν CD4, σε ανθρώπους. Ακόμη η εφεύρεση αφορά μια σύνθεση, η οποία περιλαμβάνει ένα σημασμένο πρόσδεμα με εξειδίκευση για το μόριο CD4 και κύτταρα ή σωματίδια που φέρουν CD4 καθώς και μια μέθοδο για τον προσδιορισμό του μεγέθους και της προόδου ασθενειών, στις οποίες κύτταρα που φέρουν ανθρώπινο CD4 έχουν κλινική σημασία.The invention relates to the use of a tagged ligand specific for the human CD4 molecule in the preparation of a diagnostic tool for analyzing patterns of migration and / or distribution of certain cell populations, including CD4-carrying cells, in humans. The invention further relates to a composition comprising a tagged ligand specific for the CD4 molecule and CD4-bearing cells or particles as well as a method for determining the size and progression of diseases in which human CD4-bearing cells are of clinical importance. .

CY20081100415T 2001-12-11 2008-04-15 USE A SIGNIFICANT TEMPLATE SPECIFIED FOR THE HUMAN MOTION CD4 CY1107410T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10160653 2001-12-11
DE10232189A DE10232189A1 (en) 2001-12-11 2002-07-16 Use of a labeled ligand with specificity for the human CD4 molecule for the production of a diagnostic agent for the analysis of migration and / or distribution patterns of cell populations
EP02804582A EP1454137B1 (en) 2001-12-11 2002-12-09 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations

Publications (1)

Publication Number Publication Date
CY1107410T1 true CY1107410T1 (en) 2012-12-19

Family

ID=7708699

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100415T CY1107410T1 (en) 2001-12-11 2008-04-15 USE A SIGNIFICANT TEMPLATE SPECIFIED FOR THE HUMAN MOTION CD4

Country Status (3)

Country Link
CY (1) CY1107410T1 (en)
DE (1) DE10232189A1 (en)
PT (1) PT1454137E (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4112640A1 (en) * 2021-06-29 2023-01-04 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Novel single domain antigen binding molecules and their uses

Also Published As

Publication number Publication date
DE10232189A1 (en) 2003-06-18
PT1454137E (en) 2008-05-05

Similar Documents

Publication Publication Date Title
Buck et al. Homo heidelbergensis
CY1105322T1 (en) METHODS AND COMPOSITIONS FOR THE DETECTION OF PATHOLOGICAL EVENTS
ATE438737T1 (en) METHOD FOR DETECTING DISEASES
WO2006084196A3 (en) Method for defining virtual patient populations
CY1112055T1 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LUNG TUMOR
ATE353974T1 (en) METHODS, COMPOSITIONS AND KITS FOR IDENTIFYING AND MONITORING BREAST CANCER
NO20056027L (en) Surrogate therapeutic endpoint for anti-CTLA-4 based disease immunotherapy
BRPI0411743A (en) method and compositions for treating amyloid-related diseases
DE69938662D1 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
CY1110505T1 (en) HUMAN DR4 ANTIBODIES AND THEIR USES
ATE429640T1 (en) DIAGNOSTIC ASSAY TO DETERMINE A CELL-MEDIATED IMMUNE RESPONSE
ATE548453T1 (en) MATERIALS AND METHODS INVOLVED IN THE PROTEIN AGGREGATION OF NEURODEGENERATIVE DISEASES
BR0011132A (en) Method and kit for sampling and storage of biological samples
WO2008014420A3 (en) Non-human animal models for b-cell non-hodgkin's lymphoma and uses thereof
CY1107410T1 (en) USE A SIGNIFICANT TEMPLATE SPECIFIED FOR THE HUMAN MOTION CD4
DE602004017317D1 (en) USE OF THE PROTEINS PROTEINASE 3 (PRN3) AND LEUKOCYTES ELASTATES INHIBITOR (ILEU) AS A MARKER FOR COLORECTAL CARCINOMAS
ATE352039T1 (en) METHOD FOR DETERMINING THYMIDINKINASE-1 ACTIVITY AND USE THEREOF
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
DK1454137T3 (en) Use of a labeled ligand with specificity for the human CD4 molecule
PL400309A1 (en) Nucleic acids, proteins and BTL-II antibodies
RS20060255A (en) Quick test for the diagnosis of alzheimer's disease
DE602004001994D1 (en) USE OF THE PROTEIN MASP AS A MARKER FOR COLORECTAL CARCINOMAS
WO2004091637A3 (en) System capable of treating and defining various diseases using stem cells
CA2523297A1 (en) Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte, and utilization of same
DK1407266T3 (en) Method for estimating the amount of specific neutrophil cell types